Effects of Group Cognitive-Behavioral Therapy in Young Patients in the Early Stage of Psychosis

키워드

참고문헌 (71)

1. McGorry PD, "Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages", Med J Aust, 187(7 Suppl), pp.S8~S10 (2007)
2. McGorry PD, "Early intervention in psychosis: concepts, evidence and future directions", World Psychiatry, 7, pp.148~156 (2008)
3. Perkins DO, "Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia : a critical review and meta-analysis", Am J Psychiatry, 162, pp.1785~1804 (2005)
4. Harris MG, "The relationship between duration of untreated psychosis and outcome : an eight-year prospective study", Schizophr Res, 79, pp.85~93 (2005)
5. Marshall M, "Association between duration of untreated psychosis and outcome in cohorts of first-episode patients : a systematic review", Arch Gen Psychiatry, 62, pp.975~983 (2005)
6. Norman RM, "Duration of untreated psychosis and its relationship to clinical outcome", Br J Psychiatry Suppl, 48, pp.S19~S23 (2005)
7. Chang WC, "Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia : a 3-year prospective follow-up study", Psychol Med, 43, pp.1883~1893 (2013)
8. Tang JY, "Prospective relationship between duration of untreated psychosis and 13-year clinical outcome : a first-episode psychosis study", Schizophr Res, 153, pp.1~8 (2014)
9. Compton MT, "Mode of onset of psychosis and family involvement in help-seeking as determinants of duration of untreated psychosis", Soc Psychiatry Psychiatr Epidemiol, 43, pp.975~982 (2008)
10. Birchwood M, "Early intervention in psychosis. The critical period hypothesis", Br J Psychiatry Suppl, 172, pp.53~59 (1998)
11. McGorry PD, "The recognition and optimal management of early psychosis : an evidence-based reform", World Psychiatry, 1, pp.76~83 (2002)
12. "Psychosis and schizophrenia in adults: prevention and management (Clinical guideline 178)"[URL]
13. Tarrier N, "Are all psychological treatments for psychosis equal? The need for CBT in the treatment of psychosis and not for psychodynamic psychotherapy", Psychol Psychother, 75, pp.365~374 (2002)
14. Tarrier N, "Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial", Br J Psychiatry, 184, pp.231~239 (2004)
15. Zimmermann G, "The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders : a meta-analysis", Schizophr Res, 77, pp.1~9 (2005)
16. Wykes T, "Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor", Schizophr Bull, 34, pp.523~537 (2008)
17. Mueser KT, "Psychosocial treatments for schizophrenia", Annu Rev Clin Psychol, 9, pp.465~497 (2013)
18. Lecomte T, "Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial", J Nerv Ment Dis, 196, pp.866~875 (2008)
19. Lecomte T, "Group CBT for early psychosis--are there still benefits one year later?", Int J Group Psychother, 62, pp.309~321 (2012)
20. Chung YC, "Group cognitive-behavioral therapy for early psychosis", Cognit Ther Res, 37, pp.403~411 (2013)
21. Moritz S, "Detecting and defusing cognitive traps : metacognitive intervention in schizophrenia", Curr Opin Psychiatry, 23, pp.561~569 (2010)
22. Vitzthum FB, "Individualized metacognitive therapy program for patients with psychosis(MCT+) : introduction of a novel approach for psychotic symptoms", Behav Cogn Psychother, 42, pp.105~110 (2014)
23. Moritz S, "Complementary group Metacognitive Training(MCT)reduces delusional ideation in schizophrenia", Schizophr Res, 151, pp.61~69 (2013)
24. Moritz S, "Sustained and"sleeper"effects of group metacognitive training for schizophrenia : a randomized clinical trial", JAMA Psychiatry, 71, pp.1103~1111 (2014)
25. Beck AT, "Cognitive approaches to schizophrenia : theory and therapy", Annu Rev Clin Psychol, 1, pp.577~606 (2005)
26. 유태영, "Relationship between Suicidality and Low Self-esteem in Patients with Schizophrenia", Clinical Psychopharmacology and Neuroscience, 13(3), pp.296~301 (2015), 대한정신약물학회
27. Kim SW, "Development and feasibility of smartphone application for cognitive behavioral case management of individuals with early psychosis", Early Interv Psychiatry (2016)
28. 이가영, "젊은 조현병 환자의 사회복귀를 위한 인지행동치료 기반 집중사례관리 증례", 대한조현병학회지, 19(1), pp.32~37 (2016), 대한조현병학회
29. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders", American Psychiatric Publishing, ~ (2013)
30. Naber D, "Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs", Schizophr Res, 50, pp.79~88 (2001)
31. 김성완, "단축형 항정신병약물치료 중 주관적 안녕감 척도의 표준화 연구", 대한정신약물학회지, 18(4), pp.221~230 (2007), 대한정신약물학회
32. Combs DR, "The Ambiguous Intentions Hostility Questionnaire(AIHQ) : a new measure for evaluating hostile social-cognitive biases in paranoia", Cogn Neuropsychiatry, 12, pp.128~143 (2007)
33. 장형윤, "한국어판 모호한 의도-적개심 설문지 개발", 신경정신의학, 48(1), pp.29~35 (2009), 대한신경정신의학회
34. Hogan TP, "A self-report scale predictive of drug compliance in schizophrenics : reliability and discriminative validity", Psychol Med, 13, pp.177~183 (1983)
35. 윤보현, "한국판 약물태도 척도의 심리측정적 특성", 대한정신약물학회지, 16(6), pp.480~487 (2005), 대한정신약물학회
36. Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
37. Hahn HM, "Standardization study of Beck Depression Inventory in Korea", J Korean Neuropsychiatr Assoc, 25, pp.487~502 (1986)
38. Cohen S, "The Social Psychology of Health", pp.31~67 (1988), Sage Publications, Inc
39. 이종하, "한글판 스트레스 자각척도의 신뢰도와 타당도 연구", 정신신체의학, 20(2), pp.127~134 (2012), 한국정신신체의학회
40. Guy W, "ECDEU Assessment Manual for Psychopharmacology", US Department of Mental Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, 217~222 (1976)
41. An SK, "Attribution bias in ultra-high risk for psychosis and first-episode schizophrenia", Schizophr Res, 118, pp.54~61 (2010)
42. Combs DR, "Perceptions of hostility with and without persecutory delusions", Cogn Neuropsychiatry, 14, pp.30~52 (2009)
43. Kane JM, "Comprehensive versus usual community care for first-episode psychosis : 2-year outcomes from the NIMH RAISE early treatment program", Am J Psychiatry, 173, pp.362~372 (2016)
44. Cohen J., "Statistical Power Analysis for the Behavioral Sciences" (1988), Lawrence Earlbaum Associates
45. Ussorio D, "Metacognitive training for young subjects (MCT young version) in the early stages of psychosis: is the duration of untreated psychosis a limiting factor?", Psychol Psychother, 89, pp.50~65 (2016)
46. Naeem F, "Predictors of response to cognitive behavior therapy in the treatment of schizophrenia : a comparison of brief and standard interventions", Cognit Ther Res, 32, pp.651~656 (2008)
47. Brabban A, "Predictors of outcome in brief cognitive behavior therapy for schizophrenia", Schizophr Bull, 35, pp.859~864 (2009)
48. Garety P, "London-East Anglia randomised controlled trial of cognitive-behaviour therapy for psychosis. II: Predictors of outcome", Br J Psychiatry, 171, pp.420~426 (1997)
49. Menon M, "Individual factors predicted to influence outcome in group CBT for psychosis(CBTp)and related therapies", Front Psychol, 6, pp.1563~ (2015)
50. Beauchamp MC, "Do personality traits matter when choosing a group therapy for early psychosis?", Psychol Psychother, 86, pp.19~32 (2013)
51. Uçok A, "Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia", J Psychiatr Res, 38, pp.163~168 (2004)
52. Perkins D, "Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders", Br J Psychiatry, 185, pp.18~24 (2004)
53. Rangaswamy T, "Intervention for first episode psychosis in India-The SCARF experience", Asian J Psychiatr, 5, pp.58~62 (2012)
54. Marshall M, "Impact of early intervention services on duration of untreated psychosis : data from the National EDEN prospective cohort study", Schizophr Res, 159, pp.1~6 (2014)
55. Penttilä M, "Duration of untreated psychosis as predictor of long-term outcome in schizophrenia : systematic review and meta-analysis", Br J Psychiatry, 205, pp.88~94 (2014)
56. Lappin JM, "Duration of untreated psychosis and neuropsychological function in first episode psychosis", Schizophr Res, 95, pp.103~110 (2007)
57. Malla AK, "Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis", Psychol Med, 32, pp.1109~1119 (2002)
58. Alvarez-Jiménez M, "Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis", Can J Psychiatry, 54, pp.710~718 (2009)
59. Addington J, "Duration of Untreated Psychosis in Community Treatment Settings in the United States", Psychiatr Serv, 66, pp.753~756 (2015)
60. Alvarez-Jimenez M, "Prediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis", Schizophr Res, 125, pp.236~246 (2011)
61. Bertolote J, "Early intervention and recovery for young people with early psychosis: consensus statement", Br J Psychiatry Suppl, 48, pp.S116~S119 (2005)
62. Schimmelmann BG, "Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort", J Psychiatr Res, 42, pp.982~990 (2008)
63. Moritz S, "Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics", Psychopathology, 33, pp.48~51 (2000)
64. Naber D., "A self-rating to measure subjective effects of neuroleptic drug relationships to objective psychopathology, quality of life, compliance, and other clinical variables", Int Clin Psychopharmacol, 10(Suppl 3), pp.133~138 (1995)
65. Karow A, "PANSS syndromes and quality of life in schizophrenia", Psychopathology, 38, pp.320~326 (2005)
66. Wehmeier PM, "Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.703~712 (2007)
67. Jones PB, "Randomized controlled trial of the effect on quality of life of second-versus first-generation antipsychotic drugs in schizophrenia : Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study(CUtLASS 1)", Arch Gen Psychiatry, 63, pp.1079~1087 (2006)
68. Lambert M, "Remission of severely impaired subjective well-being in 727 patients with schizophrenia treated with amisulpride", Acta Psychiatr Scand, 115, pp.106~113 (2007)
69. Kim SW, "The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 38, pp.228~235 (2012)
70. Karow A, "EGOFORS Initiative. Remission as perceived by people with schizophrenia, family members and psychiatrists", Eur Psychiatry, 27, pp.426~431 (2012)
71. Rossi A, "Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone", Int Clin Psychopharmacol, 23, pp.216~222 (2008)

관련 논문AI추천